Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer. (2019)
Attributed to:
P2X4 receptor and chronic pain - developing novel pharmacological tools to target P2X4 in the central nervous system
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1073/pnas.1815034116
PubMed Identifier: 30733293
Publication URI: http://europepmc.org/abstract/MED/30733293
Type: Journal Article/Review
Volume: 116
Parent Publication: Proceedings of the National Academy of Sciences of the United States of America
Issue: 9
ISSN: 0027-8424